BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20438080)

  • 1. Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterization.
    Taliani S; Da Pozzo E; Bellandi M; Bendinelli S; Pugliesi I; Simorini F; La Motta C; Salerno S; Marini AM; Da Settimo F; Cosimelli B; Greco G; Novellino E; Martini C
    J Med Chem; 2010 May; 53(10):4085-93. PubMed ID: 20438080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluation.
    Taliani S; Simorini F; Sergianni V; La Motta C; Da Settimo F; Cosimelli B; Abignente E; Greco G; Novellino E; Rossi L; Gremigni V; Spinetti F; Chelli B; Martini C
    J Med Chem; 2007 Jan; 50(2):404-7. PubMed ID: 17228885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.
    James ML; Fulton RR; Vercoullie J; Henderson DJ; Garreau L; Chalon S; Dolle F; Costa B; Guilloteau D; Kassiou M
    J Nucl Med; 2008 May; 49(5):814-22. PubMed ID: 18413395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator protein.
    Castellano S; Taliani S; Milite C; Pugliesi I; Da Pozzo E; Rizzetto E; Bendinelli S; Costa B; Cosconati S; Greco G; Novellino E; Sbardella G; Stefancich G; Martini C; Da Settimo F
    J Med Chem; 2012 May; 55(9):4506-10. PubMed ID: 22489952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel azido and isothiocyanato analogues of [3-(4-phenylalkylpiperazin-1-yl)propyl]bis(4-fluorophenyl)amines as potential irreversible ligands for the dopamine transporter.
    Cao J; Lever JR; Kopajtic T; Katz JL; Pham AT; Holmes ML; Justice JB; Newman AH
    J Med Chem; 2004 Dec; 47(25):6128-36. PubMed ID: 15566284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor.
    Primofiore G; Da Settimo F; Taliani S; Simorini F; Patrizi MP; Novellino E; Greco G; Abignente E; Costa B; Chelli B; Martini C
    J Med Chem; 2004 Mar; 47(7):1852-5. PubMed ID: 15027878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein.
    Margiotta N; Denora N; Ostuni R; Laquintana V; Anderson A; Johnson SW; Trapani G; Natile G
    J Med Chem; 2010 Jul; 53(14):5144-54. PubMed ID: 20568783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold.
    Cappelli A; Bini G; Valenti S; Giuliani G; Paolino M; Anzini M; Vomero S; Giorgi G; Giordani A; Stasi LP; Makovec F; Ghelardini C; Di Cesare Mannelli L; Concas A; Porcu P; Biggio G
    J Med Chem; 2011 Oct; 54(20):7165-75. PubMed ID: 21916402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).
    Reynolds A; Hanani R; Hibbs D; Damont A; Da Pozzo E; Selleri S; Dollé F; Martini C; Kassiou M
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5799-802. PubMed ID: 20727749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and structure-activity relationships of novel benzoxazolone derivatives as 18 kDa translocator protein (TSPO) ligands.
    Fukaya T; Kodo T; Ishiyama T; Kakuyama H; Nishikawa H; Baba S; Masumoto S
    Bioorg Med Chem; 2012 Sep; 20(18):5568-82. PubMed ID: 22884355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity.
    Costa B; Da Pozzo E; Chelli B; Simola N; Morelli M; Luisi M; Maccheroni M; Taliani S; Simorini F; Da Settimo F; Martini C
    Psychoneuroendocrinology; 2011 May; 36(4):463-72. PubMed ID: 20728278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and structure-activity relationship of novel tricyclic benzimidazolone derivatives as potent 18 kDa translocator protein (TSPO) ligands.
    Fukaya T; Kodo T; Ishiyama T; Nishikawa H; Baba S; Masumoto S
    Bioorg Med Chem; 2013 Mar; 21(5):1257-67. PubMed ID: 23352481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
    Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
    Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
    Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
    J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter.
    Husbands SM; Izenwasser S; Loeloff RJ; Katz JL; Bowen WD; Vilner BJ; Newman AH
    J Med Chem; 1997 Dec; 40(26):4340-46. PubMed ID: 9435903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Biological Evaluation of Novel Fluorescent Probes Targeting the 18-kDa Translocator Protein.
    Wongso H; Yamasaki T; Kumata K; Ono M; Higuchi M; Zhang MR; Fulham MJ; Katsifis A; Keller PA
    ChemMedChem; 2021 Jun; 16(12):1902-1916. PubMed ID: 33631047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making epothilones fluoresce: design, synthesis, and biological characterization of a fluorescent N12-aza-epothilone (azathilone).
    Gertsch J; Feyen F; Bützberger A; Gerber B; Pfeiffer B; Altmann KH
    Chembiochem; 2009 Oct; 10(15):2513-21. PubMed ID: 19760690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dye-labeled benzodiazepines: development of small ligands for receptor binding studies using fluorescence correlation spectroscopy.
    Hegener O; Jordan R; Häberlein H
    J Med Chem; 2004 Jul; 47(14):3600-5. PubMed ID: 15214787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A virtual screening study of the 18 kDa translocator protein using pharmacophore models combined with 3D-QSAR studies.
    Tuccinardi T; Taliani S; Bellandi M; Da Settimo F; Da Pozzo E; Martini C; Martinelli A
    ChemMedChem; 2009 Oct; 4(10):1686-94. PubMed ID: 19688807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands.
    Pike VW; Taliani S; Lohith TG; Owen DR; Pugliesi I; Da Pozzo E; Hong J; Zoghbi SS; Gunn RN; Parker CA; Rabiner EA; Fujita M; Innis RB; Martini C; Da Settimo F
    J Med Chem; 2011 Jan; 54(1):366-73. PubMed ID: 21133364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.